Community-acquired pneumonia in adults: Highlighting missed opportunities for vaccination

Francesco Blasi, Murat Akova, Paolo Bonanni, Nathalie Dartois, Evelyne Sauty, Chris Webber, Antoni Torres

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Pneumococcal pneumonia remains a clear unmet medical need for adults worldwide. Despite advances in vaccine technology, vaccination coverage remains low, putting many people at risk of significant morbidity and mortality. The herd effect seen with paediatric vaccination is not enough to protect all older and vulnerable people in the community, and more needs to be done to increase the uptake of pneumococcal vaccination in adults. Several key groups are at increased risk of contracting pneumococcal pneumonia, and eligible patients are being missed in clinical practice. At present, community-acquired pneumonia costs over €10 billion annually in Europe alone. Pneumococcal conjugate vaccination could translate into preventing 200,000 cases of community-acquired pneumonia every year in Europe alone.This group calls on governments and decision makers to implement consistent age-based vaccination strategies, and for healthcare professionals in daily clinical practice to identify eligible patients who would benefit from vaccination strategies.

Original languageEnglish
Pages (from-to)13-18
JournalEuropean Journal of Internal Medicine
Volume37
DOIs
Publication statusPublished - 2017

Fingerprint

Pneumonia
Vaccination
Pneumococcal Pneumonia
Vaccines
Pediatrics
Technology
Morbidity
Delivery of Health Care
Costs and Cost Analysis
Mortality

Keywords

  • Adult
  • Community-acquired pneumonia
  • Pneumococcal conjugate vaccine
  • Streptococcus pneumoniae

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Community-acquired pneumonia in adults : Highlighting missed opportunities for vaccination. / Blasi, Francesco; Akova, Murat; Bonanni, Paolo; Dartois, Nathalie; Sauty, Evelyne; Webber, Chris; Torres, Antoni.

In: European Journal of Internal Medicine, Vol. 37, 2017, p. 13-18.

Research output: Contribution to journalArticle

Blasi, Francesco ; Akova, Murat ; Bonanni, Paolo ; Dartois, Nathalie ; Sauty, Evelyne ; Webber, Chris ; Torres, Antoni. / Community-acquired pneumonia in adults : Highlighting missed opportunities for vaccination. In: European Journal of Internal Medicine. 2017 ; Vol. 37. pp. 13-18.
@article{d3b29473021a403d81fb2e6d94316d1e,
title = "Community-acquired pneumonia in adults: Highlighting missed opportunities for vaccination",
abstract = "Pneumococcal pneumonia remains a clear unmet medical need for adults worldwide. Despite advances in vaccine technology, vaccination coverage remains low, putting many people at risk of significant morbidity and mortality. The herd effect seen with paediatric vaccination is not enough to protect all older and vulnerable people in the community, and more needs to be done to increase the uptake of pneumococcal vaccination in adults. Several key groups are at increased risk of contracting pneumococcal pneumonia, and eligible patients are being missed in clinical practice. At present, community-acquired pneumonia costs over €10 billion annually in Europe alone. Pneumococcal conjugate vaccination could translate into preventing 200,000 cases of community-acquired pneumonia every year in Europe alone.This group calls on governments and decision makers to implement consistent age-based vaccination strategies, and for healthcare professionals in daily clinical practice to identify eligible patients who would benefit from vaccination strategies.",
keywords = "Adult, Community-acquired pneumonia, Pneumococcal conjugate vaccine, Streptococcus pneumoniae",
author = "Francesco Blasi and Murat Akova and Paolo Bonanni and Nathalie Dartois and Evelyne Sauty and Chris Webber and Antoni Torres",
year = "2017",
doi = "10.1016/j.ejim.2016.09.024",
language = "English",
volume = "37",
pages = "13--18",
journal = "European Journal of Internal Medicine",
issn = "0953-6205",
publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Community-acquired pneumonia in adults

T2 - Highlighting missed opportunities for vaccination

AU - Blasi, Francesco

AU - Akova, Murat

AU - Bonanni, Paolo

AU - Dartois, Nathalie

AU - Sauty, Evelyne

AU - Webber, Chris

AU - Torres, Antoni

PY - 2017

Y1 - 2017

N2 - Pneumococcal pneumonia remains a clear unmet medical need for adults worldwide. Despite advances in vaccine technology, vaccination coverage remains low, putting many people at risk of significant morbidity and mortality. The herd effect seen with paediatric vaccination is not enough to protect all older and vulnerable people in the community, and more needs to be done to increase the uptake of pneumococcal vaccination in adults. Several key groups are at increased risk of contracting pneumococcal pneumonia, and eligible patients are being missed in clinical practice. At present, community-acquired pneumonia costs over €10 billion annually in Europe alone. Pneumococcal conjugate vaccination could translate into preventing 200,000 cases of community-acquired pneumonia every year in Europe alone.This group calls on governments and decision makers to implement consistent age-based vaccination strategies, and for healthcare professionals in daily clinical practice to identify eligible patients who would benefit from vaccination strategies.

AB - Pneumococcal pneumonia remains a clear unmet medical need for adults worldwide. Despite advances in vaccine technology, vaccination coverage remains low, putting many people at risk of significant morbidity and mortality. The herd effect seen with paediatric vaccination is not enough to protect all older and vulnerable people in the community, and more needs to be done to increase the uptake of pneumococcal vaccination in adults. Several key groups are at increased risk of contracting pneumococcal pneumonia, and eligible patients are being missed in clinical practice. At present, community-acquired pneumonia costs over €10 billion annually in Europe alone. Pneumococcal conjugate vaccination could translate into preventing 200,000 cases of community-acquired pneumonia every year in Europe alone.This group calls on governments and decision makers to implement consistent age-based vaccination strategies, and for healthcare professionals in daily clinical practice to identify eligible patients who would benefit from vaccination strategies.

KW - Adult

KW - Community-acquired pneumonia

KW - Pneumococcal conjugate vaccine

KW - Streptococcus pneumoniae

UR - http://www.scopus.com/inward/record.url?scp=85002170688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85002170688&partnerID=8YFLogxK

U2 - 10.1016/j.ejim.2016.09.024

DO - 10.1016/j.ejim.2016.09.024

M3 - Article

AN - SCOPUS:85002170688

VL - 37

SP - 13

EP - 18

JO - European Journal of Internal Medicine

JF - European Journal of Internal Medicine

SN - 0953-6205

ER -